SEC Form 4 · accession 0001104659-15-024665
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McDonough
Officer — President and CEO · Director
Period of report
Mar 27, 2015
Accepted (ET)
Mar 31, 2015 · 3:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 | Mar 27, 2015 | M | 30,000 | $1.16 | A | 184,763 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.16 | Mar 27, 2015 | M | 30,000 | D | Jul 25, 2012 | Jan 16, 2019 | Common Stock | 30,000 | 16,806 | D |